Skip to content
Back to search results

Anticipatory Grief Scale

Introduced by
Susan K. Theut, Paul Jordan
Year
1990
Type
Self-report questionnaire
Family
pre-death-grief-assessment
Font size

What does it do?

The Anticipatory Grief Scale (AGS) is a measure developed by Theut, Jordan, and colleagues in 1990 to assess grief responses in individuals facing impending loss—such as family members caring for a terminally ill loved one or anticipating a predicted death.

The AGS captures the emotional burden, depression, existential concern, and functional disruption that often precede and accompany the final illness period, distinct from post-death grief.

The intuition behind the method

When death is anticipated (terminal illness, progressive dementia, advanced age with declining health), grief does not begin at the moment of death but rather emerges and intensifies during the illness period. Family members experience sadness, anxiety, role change, loss of function and identity, and existential questioning while the dying person is still alive—a process termed 'anticipatory grief.' This pre-death grief is phenomenologically distinct from post-death grief (bereaved individuals cannot interact with the deceased; anticipatory grievers can still speak with, care for, or say goodbye to their dying loved one). The AGS operationalizes anticipatory grief, enabling assessment of this unique, often-overlooked period of grief that can predict post-death grief intensity and caregiver burden.

History

The Anticipatory Grief Scale was developed in 1990 by Susan K. Theut, Paul Jordan, and colleagues at Johns Hopkins University as part of research on grief and health outcomes in elderly adults. The study examined family caregivers of dying or recently deceased older adults, investigating how anticipatory grief predicted depression and health outcomes. Theut's work contributed to growing recognition that the pre-death period is clinically significant and that anticipatory grief warrants assessment and support. Subsequent research in hospice, palliative care, and cancer contexts has validated and refined understanding of anticipatory grief. The AGS has been adopted in healthcare settings to identify caregivers at risk for depression and complicated grief, informing supportive interventions during end-of-life care.

When to use it

The AGS is indicated for: assessment of emotional burden in family members of terminally ill or seriously ill individuals to identify those needing support; research examining relationships between anticipatory grief and post-death outcomes (e.g., complicated grief, depression, caregiver health); outcome measurement in hospice and palliative care interventions targeting family emotional support; identification of high-risk individuals (high anticipatory grief, depression, burden) warranting intensified support; and longitudinal research tracking grief trajectories from anticipatory period through bereavement.

Limitations and considerations

  • Anticipatory grief is not uniformly negative; some research suggests that gradual adaptation before death, saying goodbye, and completing unfinished business can facilitate better post-death adjustment. The AGS measures grief burden but not adaptive processes.
  • Substantial variability in AGS scores based on illness stage and trajectory; individuals in early illness may score lower than those in active dying phase. Serial assessment across illness period is valuable but increases administrative burden.
  • Limited assessment of individual and contextual factors predicting anticipatory grief intensity; same loss context produces wide variation in anticipatory grief across individuals.
  • Relationship to post-death grief is complex: high anticipatory grief may predict greater post-death complications (loss of caregiver role, depression), but gradual adaptation may reduce post-death distress. Prognostic utility is modest.
  • Cultural variation in anticipatory grief expression not explicitly addressed; cultures vary in whether pre-death grief is openly expressed or privately experienced.

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Addresses under-recognized period of grief; acknowledges that grief begins before death and that pre-death emotional burden warrants assessment and support.
  • Practical application in healthcare settings: identifies family members at risk for poor post-death outcomes or depression during caregiving; guides supportive interventions.
  • Captures unique dimensions of anticipatory grief (role change, existential concern, preparation) distinct from post-death grief, enabling more nuanced understanding.
  • Well-validated in diverse populations (spouses of dying partners, adult children of dying parents, parents of dying children); consistently predicts post-death depression and complicated grief.
  • Brief and easy to administer in medical and hospice settings where time and respondent burden are limited.

Applications

  • Hospice and palliative care, identifying family members experiencing significant anticipatory grief burden warranting support and counselling.
  • Healthcare research examining relationships between anticipatory grief, caregiver depression/burden, and post-death outcomes in terminally ill populations.
  • Outcome measurement in family-focused hospice and palliative care interventions; assessing whether interventions reduce anticipatory grief and improve caregiver wellbeing.
  • Longitudinal research tracking grief trajectories from anticipatory period (illness) through bereavement (post-death), examining how pre-death experiences predict post-death adjustment.
  • Training of healthcare providers, hospice workers, and family counsellors in recognizing anticipatory grief and providing appropriate support during terminal illness.

How it works

How it works

1

The AGS consists of multiple items assessing emotional and behavioral responses to impending loss. Items address themes such as sadness about the anticipated loss ('I feel sad thinking about the impending death'), anxiety about the dying process ('I worry about how the death will happen'), existential concern ('I question the meaning of life'), depression and emotional burden ('I feel overwhelmed thinking about the loss'), role disruption ('My routine and relationships will change'), and preparation for death ('I am trying to say important things while I can'). Items are typically rated on a Likert scale (1 = not at all to 5 = very much). The AGS is completed by family members or close others anticipating the death, not the dying person (though adaptations exist for both). Administration takes 5–10 minutes.

Formula
Administer items assessing grief and emotional responses to impending loss
2

The AGS is scored by summing items to yield a total anticipatory grief score, with some versions calculating subscales (e.g., Depression, Existential Concern, Role Change, Preparation). Higher scores indicate greater anticipatory grief burden. Typical ranges are 0–100 (when using standardized scoring), with higher scores (>40) indicating substantial anticipatory grief. No universal diagnostic cutoff exists; interpretation is descriptive and compared to reference samples (e.g., adult children of dying parents, spouses of terminally ill partners).

Formula
Calculate total and subscale scores reflecting intensity of anticipatory grief
3

AGS interpretation is burden-focused. Low scores (<20) suggest minimal anticipatory grief—unusual in close relationships; may indicate denial, detachment, or limited emotional connection. Moderate scores (20–40) suggest typical anticipatory grief for the illness stage; emotional burden is present but manageable. High scores (>40) indicate substantial anticipatory grief with significant emotional, psychological, and possibly functional burden; caregiver depression, anxiety, and role disruption are likely; family support and potentially counselling are recommended. Interpretation should consider relationship closeness, illness duration, caregiver responsibilities, and available support.

Formula
Interpret anticipatory grief level to assess emotional burden and coping during terminal illness or expected loss

Common pitfalls

  • Assuming high AGS scores indicate pathology requiring psychiatric intervention; anticipatory grief is a normal response to impending loss. High scores indicate burden, not psychopathology; appropriate response is support and validation, not medication.
  • Failing to differentiate anticipatory grief from depression; depressive symptoms (hopelessness, anhedonia, concentration difficulty) warrant separate assessment and may require intervention beyond grief support.
  • Using AGS as sole outcome measure in hospice/palliative care without assessing post-death outcomes; anticipatory grief scores may not predict post-death adaptation equally across populations.
  • Ignoring adaptive aspects of anticipatory grief; some individuals use anticipatory grief period to prepare, say goodbye, complete legacy projects, repair relationships. These adaptive processes may not reduce AGS scores but predict better post-death outcomes.
  • Administering AGS too early in illness trajectory (e.g., at diagnosis of serious illness) before anticipatory grief has fully emerged; optimal assessment is typically when imminent death is apparent (weeks to months).

Frequently asked questions

Is anticipatory grief the same as grief after death?

No. Anticipatory grief occurs before death and involves grief about the impending loss, anxiety about the dying process, and role/identity changes coming. Post-death grief occurs after death and involves responding to the actual loss, accepting the reality, and reconstructing identity. Both are forms of grief but differ in context, focus, and available coping (you can still interact with the dying person; not with the deceased). Some aspects of anticipatory grief (saying goodbye, completing unfinished business) can facilitate post-death adaptation.

If I score high on the AGS, does that mean I'm not coping well?

High AGS scores indicate significant emotional burden from anticipatory grief—sadness, anxiety, depression about impending loss. This is often a normal response to terminal illness, not necessarily a sign of poor coping. However, if high scores are accompanied by depression (hopelessness, anhedonia), social withdrawal, or neglect of self-care, professional support is warranted. Differentiate anticipatory grief (normal) from depression (potentially requiring intervention).

Can anticipatory grief prevent complicated grief after the death?

Partially. Research shows anticipatory grief can facilitate pre-death adaptation, saying goodbye, and meaning-making, which may reduce post-death distress. However, high anticipatory grief (particularly accompanied by caregiver role burden and isolation) can also predict post-death complications, particularly loss of caregiver identity and depression. Moderate anticipatory grief with good support tends to predict the best post-death outcomes.

Should I take medication if my AGS score is high?

Medication is rarely necessary for anticipatory grief alone. First-line support includes counselling, validation, family support, meaning-making activities (legacy projects, memory work), and potentially hospice/palliative care support. Medication is indicated if depression symptoms (hopelessness, anhedonia, suicidality) emerge, which warrant psychiatric assessment. Discuss with your healthcare provider.

When should the AGS be administered during an illness?

The AGS is most meaningfully administered when the dying trajectory is clear—typically when death is expected within weeks to months, prognosis is communicated, or active dying phase is approaching. Administering at diagnosis of a serious but potentially treatable illness may be premature; anticipatory grief intensity increases as death becomes more imminent. Serial assessment across the illness period tracks grief changes over time.

Related methods

Sources

  1. Theut, S. K., Jordan, P., Ross, L. A., & Mutlak, S. (1990). Grief, depressive symptoms, and physical health in elderly adults. Journal of the American Geriatrics Society, 38(10), 1041–1048.

    Open publication reference
    Copied.